Vagus Nerve Stimulation for Post-COVID Syndrome

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 27, 2022

Primary Completion Date

January 1, 2023

Study Completion Date

January 4, 2023

Conditions
Long COVIDVagus Nerve StimulationsHeart RatesAutonomic Nervous System Disorders
Interventions
DEVICE

Auricular transcutaneous vagus nerve stimulation

Transcutaneous vagus nerve stimulation (taVNS) was performed with an FDA-approved Vagustim stimulation device and an electrode-shaped earpiece. In the participants included in the study and randomized to two groups, i) left ear taVNS was applied to the first group and ii) double-ear taVNS was applied to the second group.

Trial Locations (1)

76000

Iğdır State Hospital, Iğdır

All Listed Sponsors
lead

Bahçeşehir University

OTHER